Skip to main content
Equibles

GSK · GSK plc

Track GSK — free

Use GSK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GSK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$47.26 +0.08 (+0.17%)
Rebalance outlook locked
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 1 7.9M Avg daily vol (3M) 3.66M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$47.18 Open$48.16 Day$47.13–48.23 52W close$43.24–61.18 Avg vol 30d3.2M Short int14.7M · 0.7% float · 5.5d Short vol44% Last earningsJul 28, 2026 DataJan 2020–Oct 2026

Up next

Q1 2026 earnings call transcript
call held Apr 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+4.1%
Year over year
Operating margin
24.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year · more shares
Price change (1Y)
+11.6%
Trailing year
Short interest
0.7%
Latest settlement · 5.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Moderate
Market backdrop VIX 16.4 · calm Equity put/call 0.57
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −10%
below
Price vs 50-day avg −7%
below
RSI (14) 34
neutral
MACD trend Negative
52-week position 22%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −6%
trailing
6-month return −19%
trailing
YTD return −4%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $51 › 200d $52 — 200d above 50d
Institutional flow Accumulating
2 of 1,057 funds reported for Sep 30 · net +1.3K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.73% of float · ▲ +8.2% MoM · 5.5 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
1,057 holders — near 3-yr high, broad support
Squeeze score 53
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Moderate
Volatility 26%
annualized · 1-yr
Max drawdown −23%
past year
ATR 2.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2025
Core operating profit growth · 2026 Non-GAAP 7% – 9%
Core earnings per share growth · 2026 Non-GAAP 7% – 9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−10% Bearish
Price vs 50-day avg
−7% Bearish
RSI (14)
34 Neutral
MACD trend
Negative Bearish
52-week position
22% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $51 › 200d $52 — 200d above 50d
Institutional flow Accumulating
2 of 1,057 funds reported for Sep 30 · net +1.3K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.73% of float · ▲ +8.2% MoM · 5.5 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
1,057 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $43 Now $47 · 22% Range high $61
vs 200-day avg -10% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GSK
GSK plc
this stock
$98.62B -3.8% — — 0.7%
LLY
ELI LILLY & Co
 $1.11T +7.0% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +25.0% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +13.8% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +36.6% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,057
% held
17.5%
Reported
2 of 1,057
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
164
View
Short & Settlement
Short Interest Rising
Shares short
14.7M
Days to cover
5.5d
Change
+1.1M sh
View
Short Volume
Short vol %
44%
As of
Oct 1, 2026
Short Total
View
Fails to Deliver
FTD shares
999
Value
$50.8K
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
31.5%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 31, 2025
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 1, 2026
This year
204
View
Proposed Sales
Value
$2.3M
Shares
44.4K
Filed
Aug 20, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 23, 2026
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
GSK -5.0% -6.5% -19.0% -2.1% -3.8%
SPY -0.4% -0.2% +12.4% +0.2% +12.0%
vs SPY -4.6% -6.3% -31.4% -2.2% -15.8%
Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 29 filings 19 filers Visit website Investor relations